Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1

• Published in: Journal of molecular neuroscience Vol. 31; no. 3; pp. 273 - 279
• Main Authors: Bendova, Sarka, Krepelova, Anna, Petrak, Borivoj, Kinstova, Lenka, Musova, Zuzana, Rausova, Eva, Marikova, Tatana
• Format: Journal Article
• Language: English
• Published: United States Springer Nature B.V 01-03-2007
• Subjects: Chromatography; Chromatography, High Pressure Liquid - methods; Czech Republic; DNA Mutational Analysis; Female; Genes, Neurofibromatosis 1; Humans; Male; Mutation; Neurofibromatosis 1 - genetics; Czech Republic
• ISSN: 0895-8696; 1559-1166
• DOI: 10.1385/JMN:31:03:273

Neurofibromatosis type 1 (NF1) is one of the most common inherited human disorders, with an estimated incidence of 1 per 3500 births. In most cases, the disease is caused either by mutation in the NF1 gene, or by a particular or complete deletion of the NF1 gene. The NF1 gene exhibits one of the highest mutation rates of any human disorder. In this experimental study of the NF1 gene, we screened the mutational spectrum of 22 unrelated patients from the Czech Republic using the denaturing high-performance liquid chromatography (DHPLC) and multiplex ligation-dependent probe amplification (MLPA) methods. We found NF1 mutations in 17 patients: 15 causal mutations were detected with the use of the DHPLC method (15/20, 75%). With the MPLA method, we also confirmed and specified two large deletions that were previously genotyped by microsatellite markers. Twelve of the above-mentioned mutations were newly found: c.1_2delATinsCC, c.1185+1G>C, c.1757_1760delCTAG, c.1642-7A>G, c.2329 T>G, c.2816delA, c.3738_3741delGTTT, c.4733 C>T, c.5220delT, c.6473_6474insGAAG, ex14_49del, ex28_49del. We present this study as a first effectual step in the routine diagnosis of the NF1 in patients from the Czech Republic.